BA170275 - targeted therapeutics for orthopedic regeneration
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH18C0182
- Awardee
-
The Geneva Foundation UEI TR9RX33188T4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,477,474
Award facts
- Opportunity
-
- W81XWH17RBAA1 Solicitation number
- FY17 USAMRMC Broad Agency Announcement Award Notice · Posted Sep 30, 2016
- Contract value 100% obligated
- $1,477,474.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$26 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $227,500 | |
| Original award | $1,250,000 |
About this award
The Defense Health Agency awarded a $1,477,474.30 cost-no-fee definitive contract to The Geneva Foundation for targeted therapeutics for orthopedic regeneration. The contract calls for the Foundation to deliver evaluation of a platform technology to render orthopedic implants biologically active in a single-step procedure. Major subcontractors include Theradaptive Inc. to support the evaluation and John Greenbaum as a regulatory consultant. Theradaptive will apply its experience developing conformable scaffolds and sustained-release implants to advance orthopedic repair technologies under the contract. The Foundation utilizes its expertise conducting military medical research through the Military Medical Research and Development program to support the Defense Health Agency's goal of transforming battlefield medicine. No set-aside designation was used for this award made to the non-profit Foundation, which has extensive experience as both a prime contractor and subawardee on projects related to combat trauma treatments, musculoskeletal injuries, and other priorities.
Quick answers
Who was awarded contract W81XWH18C0182?
W81XWH18C0182 was awarded to The Geneva Foundation by Defense Health Agency (Department of Defense) on September 21, 2018.
How much is contract W81XWH18C0182 worth?
The government has obligated $1,477,474 on W81XWH18C0182.
Was contract W81XWH18C0182 competed?
The extent of competition for W81XWH18C0182 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award